Mansfield Fellow Addresses Tokyo Symposium
Mansfield Fellow Addresses Tokyo Symposium
April 20, 2017
Earlier this month Mansfield Fellow Kenneth Cavanaugh (U.S. Food and Drug Administration, FDA) attended the 3rd Annual Drug Information Association Medical Device Development Symposium in Tokyo. The symposium was attended by over 100 professionals involved in the development, sales, and regulation of medical products in Japan. The goal of the symposium was to rethink the most appropriate strategies for clinical evaluation of innovative medical devices in Japan, with the aim of accelerating physician and patient access to promising new therapies. During the symposium, Dr. Cavanaugh presented an overview of the current U.S. environment in this area, including emerging regulatory policy, recent examples of novel approaches to clinical evidence collection and analysis, past and future opportunities for U.S.-Japanese collaboration, and potential changes in these areas over the next few years. Dr. Cavanaugh is Associate Director of the Division of Cardiovascular Devices at FDA. His current placement is with Japan’s Pharmaceuticals and Medical Devices Agency.
